(Q51481449)

English

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

scientific article published in July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

type 2 diabetes

0 references

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Anthony S Wierzbicki

7

object named as

Anthony S Wierzbicki

1 reference

Europe PubMed Central

5 April 2018

author name string

Bernard Chappuis

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Monika Braun

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Christoph Stettler

3

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Sabine Allemann

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Peter Diem

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Peter J Lumb

6

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Richard James

8

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

publication date

1 July 2007

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

23

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

392-399

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

Lipoprotein heterogeneity and apolipoprotein B metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

21 January 2018

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglycerides and endothelial function in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical fitness and reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic basis of hypotriglyceridemic effects of insulin in normal men

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel PPARgamma-dependent and independent effects for thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Global structure and dynamics of human apolipoprotein CII in complex with micelles: evidence for increased mobility of the helix involved in the activation of lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.715

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.715

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17211855

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51481449&oldid=1512252093"